Publications 2017

262.
Cherney D, Perkins BA, Lytvyn Y, Heerspink H, Rodríguez-Ortiz ME, Mischak H.
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome.
PLoS One. 2017 Oct 30;12(10):e0186910. doi: 10.1371/journal.pone.0186910. eCollection 2017. PMID: 29084249 Free Article

View AbstractDownload     Request Reprint
 

261.
Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A.
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19. PMID: 29050215 Free PMC Article

View AbstractDownload     Request Reprint
 

260.
Markoska K, Pejchinovski M, Pontillo C, Zürbig P, Jacobs L, Smith A, Masin-Spasovska J, Stojceva-Taneva O, Polenakovic M, Magni F, Mischak H, Spasovski G.
Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.
Nephrol Dial Transplant. 2017 Sep 1. doi: 10.1093/ndt/gfx263. [Epub ahead of print] PMID: 28992073

View AbstractDownload     Request Reprint
 

259.
Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H.
Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Proteomics Clin Appl. 2017 Oct 5. doi: 10.1002/prca.201700074. [Epub ahead of print] Review. PMID: 28980455

View AbstractDownload     Request Reprint
 

258.
Zhang ZY, Ravassa S, Pejchinovski M, Yang WY, Zürbig P, López B, Wei FF, Thijs L, Jacobs L, González A, Voigt JU, Verhamme P, Kuznetsova T, Díez J, Mischak H, Staessen JA.
A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population.
Kidney Int Rep. 2017 Sep;2(5):811-820. doi: 10.1016/j.ekir.2017.03.012. PMID: 28920100 Free PMC Article

View AbstractDownload     Request Reprint
 

257.
Krochmal M, Cisek K, Filip S, Markoska K, Orange C, Zoidakis J, Gakiopoulou C, Spasovski G, Mischak H, Delles C, Vlahou A, Jankowski J.
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.
Sci Rep. 2017 Aug 22;7(1):9091. doi: 10.1038/s41598-017-09393-w. PMID: 28831120 Free PMC Article

View AbstractDownload     Request Reprint
 

256.
Voigtländer T, Metzger J, Schönemeier B, Jäger M, Mischak H, Manns MP, Lankisch TO.
A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin.
United European Gastroenterol J. 2017 Aug;5(5):668-676. doi: 10.1177/2050640616687836. Epub 2017 Jan 11. PMID: 28815030 Free PMC Article

View AbstractDownload     Request Reprint
 

255.
Zhang ZY, Ravassa S, Nkuipou-Kenfack E, Yang WY, Kerr SM, Koeck T, Campbell A, Kuznetsova T, Mischak H, Padmanabhan S, Dominiczak AF, Delles C, Staessen JA.
Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure.
J Am Heart Assoc. 2017 Aug 7;6(8). pii: e005432. doi: 10.1161/JAHA.116.005432. PMID: 28784649 Free PMC Article

View AbstractDownload     Request Reprint
 

254.
Latosinska A, Hulko M, Speidel R, Mischak H, Storr M, Krause B.
Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
Artif Organs. 2017 Jul 26. doi: 10.1111/aor.12952. [Epub ahead of print] PMID: 28744941

View AbstractDownload     Request Reprint
 

253.
Pontillo C, Mischak H.
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.
Clin Kidney J. 2017 Apr;10(2):192-201. doi: 10.1093/ckj/sfx002. Epub 2017 Mar 29. PMID: 28694965 Free PMC Article

View AbstractDownload     Request Reprint
 

252.
Pejchinovski M, Siwy J, Mullen W, Mischak H, Petri MA, Burkly LC, Wei R.
Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.
Lupus. 2017 Jan 1:961203317707827. doi: 10.1177/0961203317707827. [Epub ahead of print] PMID: 28474961

View AbstractDownload     Request Reprint
 

251.
Wei R, Gao B, Shih F, Ranger A, Dearth A, Mischak H, Siwy J, Wisniacki N, Petri M, Burkly LC.
Alterations in urinary collagen peptides in lupus nephritis subjects correlate with renal dysfunction and renal histopathology.
Nephrol Dial Transplant. 2017 Sep 1;32(9):1468-1477. doi: 10.1093/ndt/gfw446. PMID: 28339802

View AbstractDownload     Request Reprint
 

250.
Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S.
Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Int J Chron Obstruct Pulmon Dis. 2017 Mar 8;12:829-837. doi: 10.2147/COPD.S125240. eCollection 2017. PMID: 28331304 Free PMC Article

View AbstractDownload     Request Reprint
 

249.
Htun NM, Magliano DJ, Zhang ZY, Lyons J, Petit T, Nkuipou-Kenfack E, Ramirez-Torres A, von Zur Muhlen C, Maahs D, Schanstra JP, Pontillo C, Pejchinovski M, Snell-Bergeon JK, Delles C, Mischak H, Staessen JA, Shaw JE, Koeck T, Peter K.
Prediction of acute coronary syndromes by urinary proteome analysis.
PLoS One. 2017 Mar 8;12(3):e0172036. doi: 10.1371/journal.pone.0172036. eCollection 2017. PMID: 28273075 Free PMC Article

View AbstractDownload     Request Reprint
 

248.
Dacheva I, Reich M, Nobl M, Ceglowska K, Wasiak J, Siwy J, Zürbig P, Mischak H, Koch FH, Kopitz J, Kretz FT, Tandogan T, Auffarth GU, Koss MJ.
[Proteome analysis of undiluted vitreous humor in patients with branch retinal vein occlusion].
Ophthalmologe. 2017 Feb 28. doi: 10.1007/s00347-017-0469-z. [Epub ahead of print] German. PMID: 28247073

View AbstractDownload     Request Reprint
 

247.
Nkuipou-Kenfack E, Schanstra JP, Bajwa S, Pejchinovski M, Vinel C, Dray C, Valet P, Bascands JL, Vlahou A, Koeck T, Borries M, Busch H, Bechtel-Walz W, Huber TB, Rudolph KL, Pich A, Mischak H, Zürbig P.
The use of urinary proteomics in the assessment of suitability of mouse models for ageing.
PLoS One. 2017 Feb 15;12(2):e0166875. doi: 10.1371/journal.pone.0166875. eCollection 2017. PMID: 28199320 Free PMC Article

View AbstractDownload     Request Reprint
 

246.
Albalat A, Mullen W, Husi H, Mischak H.
Tissue Proteomics in Vascular Disease.
Methods Mol Biol. 2017;1527:53-60. doi: 10.1007/978-1-4939-6625-7_4. PMID: 28116706

View AbstractDownload     Request Reprint
 

245.
Siebert S, Porter D, Paterson C, Hampson R, Gaya D, Latosinska A, Mischak H, Schanstra J, Mullen W, McInnes I.
Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups.
Sci Rep. 2017 Jan 16;7:40473. doi: 10.1038/srep40473. PMID: 28091549 Free PMC Article

View AbstractDownload     Request Reprint
 

244.
Lindhardt M, Persson F, Oxlund C, Jacobsen IA, Zürbig P, Mischak H, Rossing P, Heerspink HJ.
Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.
Nephrol Dial Transplant. 2017 Jan 7. pii: gfw406. doi: 10.1093/ndt/gfw406. [Epub ahead of print] PMID: 28064163

View AbstractDownload     Request Reprint
 

243.
Nkuipou-Kenfack E, Zürbig P, Mischak H.
The long path towards implementation of clinical proteomics: Exemplified based on CKD273.
Proteomics Clin Appl. 2017 May;11(5-6). doi: 10.1002/prca.201600104. Epub 2017 Jan 17. Review. PMID: 28019083

View AbstractDownload     Request Reprint
 

242.
Mokou M, Lygirou V, Vlahou A, Mischak H.
Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.
Expert Rev Proteomics. 2017 Feb;14(2):117-136. doi: 10.1080/14789450.2017.1274653. Epub 2017 Jan 5. Review. PMID: 27997814

View AbstractDownload     Request Reprint